$0.4490
-0.01-2.24%
In chiusura: -
$0.4420
-0.00700-1.56%
After hour: Oct 3, 7:55 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Harvard Bioscience segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 6
Stima EPS
$0.010
Stima dei ricavi trimestrali
$20.00M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$88.75M
Analizza lo storico degli utili di Harvard Bioscience utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HBIO | Harvard Bioscience | -$0.02 | $0.01 | — | — | $21.97M | $20.00M | — | — | 11/06/2025 | |
HBIO | Harvard Bioscience | $0.00 | -$0.02 | -$0.01 | 50.00% | $23.10M | $18.75M | $20.45M | 9.07% | 08/11/2025 | |
HBIO | Harvard Bioscience | $0.02 | -$0.04 | -$0.01 | 75.00% | $24.51M | $19.20M | $21.77M | 13.41% | 05/12/2025 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.06 | 20.00% | $28.15M | $24.15M | $24.56M | 1.68% | 03/12/2025 | |
HBIO | Harvard Bioscience | $0.01 | $0.03 | -$0.02 | -166.67% | $25.36M | $25.30M | $21.97M | -13.16% | 11/07/2024 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.00 | -100.00% | $28.76M | $26.40M | $23.10M | -12.51% | 08/08/2024 | |
HBIO | Harvard Bioscience | $0.06 | $0.02 | $0.02 | 0.00% | $29.98M | $25.79M | $24.51M | -4.96% | 05/07/2024 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.04 | -20.00% | $28.43M | $29.11M | $28.15M | -3.29% | 03/07/2024 | |
HBIO | Harvard Bioscience | -$0.01 | $0.04 | $0.01 | -75.00% | $26.92M | $28.02M | $25.36M | -9.48% | 11/07/2023 | |
HBIO | Harvard Bioscience | $0.05 | $0.05 | $0.04 | -20.00% | $29.21M | $29.50M | $28.76M | -2.51% | 08/08/2023 | |
HBIO | Harvard Bioscience | $0.04 | $0.05 | $0.06 | 20.00% | $28.78M | $28.85M | $29.98M | 3.90% | 04/25/2023 | |
HBIO | Harvard Bioscience | $0.08 | $0.03 | $0.04 | 33.33% | $33.05M | $30.33M | $28.43M | -6.27% | 03/09/2023 | |
HBIO | Harvard Bioscience | $0.06 | $0.07 | -$0.01 | -114.29% | $29.66M | $28.89M | $26.92M | -6.81% | 11/08/2022 | |
HBIO | Harvard Bioscience | $0.06 | $0.06 | $0.05 | -16.67% | $29.20M | $30.49M | $29.21M | -4.20% | 08/03/2022 | |
HBIO | Harvard Bioscience | $0.05 | $0.05 | $0.04 | -20.00% | $26.99M | $28.77M | $28.78M | 0.03% | 05/04/2022 | |
HBIO | Harvard Bioscience | $0.08 | $0.10 | $0.08 | -20.00% | $30.98M | $32.96M | $33.05M | 0.29% | 03/08/2022 | |
HBIO | Harvard Bioscience | $0.04 | $0.06 | $0.06 | 0.00% | $24.04M | $27.91M | $29.66M | 6.28% | 11/03/2021 | |
HBIO | Harvard Bioscience | $0.05 | $0.06 | $0.06 | 0.00% | $23.31M | $27.67M | $29.20M | 5.52% | 08/05/2021 | |
HBIO | Harvard Bioscience | -$0.01 | $0.03 | $0.05 | 66.67% | $23.77M | $25.73M | $26.99M | 4.89% | 05/06/2021 | |
HBIO | Harvard Bioscience | $0.08 | $0.06 | $0.08 | 33.33% | $30.97M | $27.13M | $30.98M | 14.21% | 03/10/2021 | |
HBIO | Harvard Bioscience | $0.04 | $0.03 | $0.04 | 33.33% | $27.42M | $24.05M | $24.04M | -0.05% | 11/05/2020 |
Harvard Bioscience (HBIO) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-0.01 | $-0.02 | 50.0 % |
| Q1 | 2025-05-12 | $-0.01 | $-0.04 | 75.0 % |
| Q4 | 2025-03-12 | $0.06 | $0.05 | 20.0 % |
| Q3 | 2024-11-07 | $-0.02 | $0.03 | -166.7 % |
Harvard Bioscience (HBIO) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $20.45M | $18.75M | 9.07 % |
| Q1 | 2025-05-12 | $21.77M | $19.20M | 13.4 % |
| Q4 | 2025-03-12 | $24.56M | $24.15M | 1.68 % |
| Q3 | 2024-11-07 | $21.97M | $25.30M | -13.2 % |
FAQ
Quando Harvard Bioscience (NASDAQ:HBIO) riporterà gli utili?
Si prevede che Harvard Bioscience (HBIO) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Harvard Bioscience (NASDAQ:HBIO)?
L'EPS effettivo era $-0.01, che superato la stima di $-0.02.
Quali sono state le entrate di Harvard Bioscience (NASDAQ:HBIO)?
Le entrate effettive sono state $20.4M, che superato la stima di $18.8M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.